Cancer Colon
18
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Perioperative Iron for Colorectal Cancer (PICoC Study)
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Clinical and Biological Database in Colon Cancer and Colic Tumors
Quest to Analyze One Thousand Humans Meditating
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Significance of Cortactin Expression in Colorectal Adenocarcinomas
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients
Laparoscopic Colectomies In Management of Colonic Cancers
The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment
Early Palliative Care Integration in Interventional Cancer Care
Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.
Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy